Paxlovid
- Covid-19 News
Pfizer CEO Albert Bourla diagnosed with an unfortunate infection
If you’ve ever heard the advice “never get a haircut from a bald barber” you know that even something completely natural can tarnish the image of a brand in people’s minds. So, much like being judged for being an overweight fitness instructor, it’s a bit awkward for Albert Bourla that people now know he’s been infected by Covid-19, considering he…
- Covid-19 News
Pfizer Covid-19 treatment, Paxlovid, “strongly recommended” by WHO
The World Health Organisation has given its backing to Pfizer’s Covid-19 treatment, Paxlovid, recommending it over the alternatives. The WHO says it “strongly recommends” the treatment for Covid patients with milder symptoms, who remain at high risk of being hospitalised. However, it adds that, as with vaccines, inequality in accessing the drug remains a problem for lower and middle-income countries.…
- Covid-19 News
Thai government signs procurement deal for 2 million Paxlovid tablets
Thailand’s Department of Medical Services has signed a deal with Pfizer to purchase 2 million Paxlovid tablets for the treatment of Covid-19. This equates to 50 treatment courses of the anti-viral medication, with delivery expected next month, according to a Thai PBS World report. DMS director Dr. Somsak Akksilp says that clinical trials have shown the drug can reduce the…
- Thailand video news
Thailand News Today | More competition for thai taxis!
A leading epidemiologist has questioned Thailand’s rush to declare Covid endemic as infections and deaths surge. Dr. Chakrarat, director of the Bureau of Epidemiology, is suggesting officials slow down a bit, as he casts doubt on the wisdom of trying to declare the virus endemic by July 1. Despite raising the country’s alert level to level 4 on February 21,…
- Covid-19 News
Pfizer Covid-19 pill nearly 90% effective at preventing hospitalisation, death
The pharmaceutical firm Pfizer says there have been highly promising results from the final analysis of its new Covid-19 treatment. The antiviral pill, which, if approved, will be sold as Paxlovid, has been shown to be nearly 90% effective at preventing hospitalisation and death in high-risk patients. Furthermore, recent data appears to show that the pill remains effective against the…
- Covid-19 News
Paxlovid deal allows generics of Covid-19 treatment for 95 countries
Pfizer struck a deal with Medicines Patent Pool to allow generic drug manufacturers to produce its new Paxlovid antiviral Covid-19 pills cheaply for less wealthy countries. The deal was announced yesterday and will bring down the cost of the Covid-19 treatment course for 95 countries that are considered low and middle-income. The access covers about 53% of the world population.…
- Covid-19 News
Covid-19 medications are a boon, but don’t replace vaccines
The good news of several new anti-viral pills that have shown to be effective in greatly reducing Covid-19 hospitalisations and deaths, coupled with statistically rare vaccine side effects or deaths that some people latch onto, may tempt many to skip getting vaccinated and rely solely on medication once they get infected. But a Thai expert on crisis communication with the…
- Covid-19 News
Thai government to stock up on new Covid-19 treatments
Thailand’s Public Health Ministry plans to order 2 types of antiviral oral treatment in its fight against Covid-19. The Bangkok Post reports that the ministry wants to order supplies of the Molnupiravir antiviral pill, as well as Pfizer’s new oral treatment, Paxlovid. Dr Atthasit Srisubat from the Department of Medical Services has confirmed the decision, following the recent order from PM…
- Covid-19 News
Paxlovid by Pfizer reduces Covid-19 hospitalisation, death by 89%
Hot on the tail of Merck winning approval for use in the UK for its anti-viral Molnupiravir pill treatment, Pfizer announced yesterday that clinical trials show their new drug, Paxlovid, to be highly effective in treating Covid-19. The pharmaceutical giant was quick to point out that their pill was developed with the specific goal of fighting Covid-19, unlike the Merck…
